| Members |
targetComponentId |
| Pain of oral cavity structure |
Pain of region of internal part of mouth (finding) |
| Painful ejaculation |
Painful ejaculation |
| Palatal flap |
Flap (substance) |
| Palatoplasty |
Uvulopalatopharyngoplasty |
| Pale faeces |
Pale feces |
| Pale faeces |
Pale feces |
| Pale feces symptom |
Pale feces |
| Pale red color |
Pale red colour |
| Pamidronate disodium 3mg/mL infusion concentrate 5mL vial |
Product containing precisely disodium pamidronate 3 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Pancreas excision |
Pancreatectomy |
| Pancrelipase, amylase:lipase 183.49mg capsule |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pancrelipase, amylase:lipase 184.84mg capsule |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pancrelipase, amylase:lipase 210.33mg capsule |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pancrelipase, amylase:lipase 278.72% capsule |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pancrelipase, amylase:lipase 312.17mg capsule |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pancrelipase, amylase:lipase 346.86mg capsule |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pancrelipase, amylase:lipase 4500unit capsule |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pancrelipase, amylase:lipase 62.81% |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pancrelipase, amylase:lipase 62.81% capsule |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pancrelipase, amylase:lipase 94.3mg capsule |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pantoprazole sodium 40mg injection |
Pantoprazole (as pantoprazole sodium) 40 mg powder for solution for injection vial |
| Pantoprazole sodium 40mg m/r tablet |
Pantoprazole (as pantoprazole sodium) 40 mg gastro-resistant oral tablet |
| Pantoprazole sodium 40mg powder |
Pantoprazole (as pantoprazole sodium) 40 mg powder for solution for injection vial |
| Pantoprazole sodium 40mg/vial powder for injection |
Pantoprazole (as pantoprazole sodium) 40 mg powder for solution for injection vial |
| Papain specific extract |
Product containing papain (medicinal product) |
| Papaya - dietary |
Papaya (substance) |
| Paphosia adorabilis |
Lophornis adorabilis (organism) |
| Papillary cystadenoma, borderline malignancy |
Papillary cystadenoma, borderline malignancy |
| Papillary mucinous cystadenoma, borderline malignancy |
Papillary mucinous cystadenoma, borderline malignancy |
| Papillary serous cystadenocarcinoma |
Serous cystadenocarcinoma |
| Papillary serous cystadenoma, borderline malignancy |
Serous papillary cystic tumour of borderline malignancy |
| Papilloma, no International Classification of Diseases for Oncology subtype (except papilloma of bladder M-81201) |
Benign papilloma (morphologic abnormality) |
| Para-aminophenol derivative anti-inflammatory agent |
Para-aminophenol derivative |
| Paracetamol + chlorpheniramine maleate + phenylephrine hydrochloride 500mg/8mg/40mg |
Product containing only chlorphenamine and paracetamol and phenylephrine (medicinal product) |
| Paracetamol + orphenadrine citrate 500mg/50mg |
Orphenadrine and paracetamol only product |
| Paracetamol - chemical |
Product containing paracetamol (medicinal product) |
| Paracetamol 1g/sachet powder |
Paracetamol only product |
| Paracetamol 1g/sachet powder |
Paracetamol only product |
| Paracetamol 500mg soluble tablet |
Product containing precisely paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
| Paracetamol 650mg / pentazocine hydrochloride 25mg caplet |
Paracetamol 650 mg and pentazocine 25 mg oral tablet |
| Paracetamol 650mg / pentazocine hydrochloride 25mg conventional release oral tablet |
Paracetamol 650 mg and pentazocine 25 mg oral tablet |
| Paracetamol level abnormal |
Acetaminophen above therapeutic range |
| Paracetamol level normal |
Acetaminophen within therapeutic range |
| Paracetamol+caffeine 500mg/65mg soluble tablet |
Product containing precisely caffeine 650 microgram/1 milliliter and paracetamol 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Parafollicular cell carcinoma |
Medullary thyroid carcinoma |
| Parafunctional occlusal trauma |
Secondary occlusal trauma |
| Parahyaena brunnea |
Hyaena brunnea (organism) |
| Paramyxovirus |
Genus Respirovirus (organism) |
| Paramyxovirus group |
Genus Respirovirus (organism) |
| Paraplegia, brachydactyly, cone-shaped epiphysis syndrome |
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (disorder) |
| Parascapular fasciocutaneous flap |
Fasciocutaneous flap |
| Parascapular fasciocutaneous flap plus scapula |
Osteofasciocutaneous flap (substance) |
| Parasomnia disorder caused by substance |
Parasomnia |
| Parathormone |
Parathyroid hormone |
| Parathyroid hormone-related peptide-secreting tumor |
Parathyroid hormone-related peptide-secreting tumor of pancreas (disorder) |
| Paratyphoid exanthem |
Eruption of skin caused by Salmonella Paratyphi |
| Parecoxib 40mg (injection pdr for recon) |
Parecoxib only product |
| Parecoxib 40mg injection (pdr for recon)+diluent |
Parecoxib only product |
| Parecoxib 40mg injection (pdr for recon)+diluent |
Parecoxib only product |
| Parent is handicapped |
Parent has disability |
| Parent of subject |
Parent |
| Parental reassurance |
Providing reassurance to parent |
| Parental reassurance |
Providing reassurance to parent |
| Parenteral glyceryl trinitrate allergy |
Allergy to nitroglycerin |
| Parenteral intake process |
Introduction procedure (procedure) |
| Parenteral isoprenaline allergy |
Allergy to isoprenaline |
| Parenteral isosorbide dinitrate allergy |
Allergy to isosorbide (finding) |
| Parenteral potassium allergy |
Propensity to adverse reaction to potassium (finding) |
| Parkinson-dementia complex of Guam |
Amyotrophic lateral sclerosis, parkinsonism, dementia complex |
| Paromomycin |
Paromomycin |
| Paroophoron |
Wolffian body rest |
| Paroxetine 12.5mg gastro-resistant and prolonged-release oral tablet |
Product containing only paroxetine in oral dose form (medicinal product form) |
| Paroxetine 12.5mg tablet controlled-release |
Product containing only paroxetine in oral dose form (medicinal product form) |
| Paroxetine 25mg gastro-resistant and prolonged-release oral tablet |
Product containing only paroxetine in oral dose form (medicinal product form) |
| Paroxetine 25mg tablet controlled-release |
Product containing only paroxetine in oral dose form (medicinal product form) |
| Paroxetine 37.5mg gastro-resistant and prolonged-release oral tablet |
Product containing only paroxetine in oral dose form (medicinal product form) |
| Paroxetine 37.5mg tablet controlled-release |
Product containing only paroxetine in oral dose form (medicinal product form) |
| Paroxetine hydrochloride 10mg tablet |
Product containing precisely paroxetine (as paroxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) |
| Paroxetine mesylate 10mg tablet |
Product containing precisely paroxetine (as paroxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) |
| Parsley - dietary |
Parsley (substance) |
| Parsley - dietary |
Parsley (substance) |
| Partial avulsion of nail |
Partial excision of nail and nail matrix |
| Partial avulsion of tooth |
Extrusive luxation of tooth |
| Partial division of tendon of muscle of eye, otherwise specified |
Partial division of tendon of muscle of eye |
| Partial epileptic seizure of frontal lobe with impairment of consciousness |
Frontal lobe epileptic seizure (finding) |
| Partial epileptic seizure of occipital lobe with impairment of consciousness |
Occipital lobe epileptic seizure |
| Partial epileptic seizure of parietal lobe with impairment of consciousness |
Parietal lobe epileptic seizure (finding) |
| Partial epileptic seizure of temporal lobe with impairment of consciousness |
Temporal lobe epileptic seizure |
| Partial excision of femur |
Partial ostectomy of femur |
| Partial excision of organ NOC |
Partial excision (procedure) |
| Partial excision of pituitary gland by unspecified approach |
Partial hypophysectomy |
| Partial hysterectomy |
Subtotal abdominal hysterectomy |
| Partial hysterectomy |
Subtotal abdominal hysterectomy |
| Partial recent retinal detachment with multiple defects |
Partial detachment of retina with multiple breaks of retina (disorder) |
| Partial recent retinal detachment with single defect |
Partial detachment of retina with single break of retina (disorder) |
| Partial replacement of joint of bilateral shoulder regions |
Partial replacement of joint of bilateral shoulders (procedure) |
| Partial seizure with illusions and hallucinations |
Focal onset cognitive epileptic seizure |
| Partial thickness skin graft |
Split thickness graft of skin (substance) |
| Partner had vasectomy |
Partner had vasectomy (situation) |
| Partner had vasectomy |
Partner had vasectomy (situation) |
| Partner in relationship with subject |
Partner in relationship |
FHIR